Page last updated: 2024-09-04

beta-lactams and Infection, Pelvic

beta-lactams has been researched along with Infection, Pelvic in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Citron, DM; Goldstein, EJ; Motyl, M; Pelak, BA; Teppler, H; Woods, GL1
Gesser, R; McCarroll, K; Tellado, J; Teppler, H; Woods, GL1
Gesser, RM; McCarroll, K; Teppler, H; Woods, GL1
Adeyi, B; Angel-Muller, E; Hague, C; Higareda, I; Ismail, M; Roy, S; Teppler, H; Woods, GL1
Gesser, RM; Graham, DR; Meibohm, AR; Roy, S; Solomkin, J; Teppler, H; Woods, GL1

Trials

4 trial(s) available for beta-lactams and Infection, Pelvic

ArticleYear
Ertapenem versus piperacillin-tazobactam for treatment of mixed anaerobic complicated intra-abdominal, complicated skin and skin structure, and acute pelvic infections.
    Surgical infections, 2002,Winter, Volume: 3, Issue:4

    Topics: Abdomen; Adult; Aged; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Ertapenem; Female; Humans; Lactams; Male; Middle Aged; Pelvic Infection; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Skin Diseases, Bacterial; Surgical Wound Infection

2002
Surgical infections with enterococcus: outcome in patients treated with ertapenem versus piperacillin-tazobactam.
    Surgical infections, 2002,Winter, Volume: 3, Issue:4

    Topics: Abdomen; Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Enterococcus; Ertapenem; Female; Gram-Positive Bacterial Infections; Humans; Lactams; Male; Middle Aged; Pelvic Infection; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Skin Diseases, Bacterial; Surgical Wound Infection; Treatment Outcome

2002
Ertapenem once a day versus piperacillin-tazobactam every 6 hours for treatment of acute pelvic infections: a prospective, multicenter, randomized, double-blind study.
    Infectious diseases in obstetrics and gynecology, 2003, Volume: 11, Issue:1

    Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Confidence Intervals; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Ertapenem; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Lactams; Middle Aged; Pelvic Infection; Penicillanic Acid; Piperacillin; Probability; Prospective Studies; Risk Assessment; Severity of Illness Index; Tazobactam; Treatment Outcome

2003
Treatment of polymicrobial infections: post hoc analysis of three trials comparing ertapenem and piperacillin-tazobactam.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 53 Suppl 2

    Topics: Abdomen; Adolescent; Adult; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Double-Blind Method; Ertapenem; Female; Humans; Lactams; Male; Pelvic Infection; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Skin Diseases, Bacterial; Treatment Outcome

2004

Other Studies

1 other study(ies) available for beta-lactams and Infection, Pelvic

ArticleYear
Comparative in vitro activities of ertapenem against bacterial pathogens from patients with acute pelvic infection.
    The Journal of antimicrobial chemotherapy, 2002, Volume: 50, Issue:5

    Topics: Acute Disease; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Ertapenem; Humans; Lactams; Microbial Sensitivity Tests; Pelvic Infection

2002